What does Everolimus 0.25mg Tablet have to do with anything?
Everolimus 0.25mg Tablet (Zortress) is a medicine that is used in combination with other medications to avoid transplant rejection (the immune system of the person who got the organ attacking the donated organ). It is used in certain adults who have had kidney transplants. Everolimus belongs to the kinase inhibitor class of drugs.
Everolimus is a type of medicine?
Everolimus, better known by its brand name Afinitor, is a targeted cancer medication that inhibits cancer growth. If you have advanced: you may have everolimus. Breast cancer has a positive hormone receptor. A neuroendocrine tumor (NET) is a type of cancer that develops in the stomach, intestines, lungs, or pancreas.
What are the everolimus side effects?
- Face, arms, hands, lower legs, or feet bloating or swelling.
- a nasal bleed
- Tightness or soreness in the chest.
- Weight loss was achieved.
- Breathing that is laborious or labored.
- swallowing difficulties
- and overall feeling of unease or disease
- hoarseness. For more details Click Here.
Is there a limit to how long you can take Everolimus 0.25mg Tablet Evergraf?
Everolimus 0.25mg Tablet Evergraf is normally taken once a day for as long as it is effective or until it causes unacceptable adverse effects. It is intended to be used as a long-term remedy. The average treatment time in clinical studies was around 24.0 weeks (ranging from one week to almost 200 weeks).
Is it true that Everolimus 0.25mg Tablet Evergraf causes weight loss?
EFFECTS OF SIDE EFFECTS: Diarrhea, nausea/vomiting, loss of appetite, weight loss, taste changes, nosebleeds, dry skin, dizziness, and headache are all possible side effects. If any problem side effects persist or worsen, contact your doctor straight away.
Is it true that everolimus causes weight gain?
Fluid retention is a side effect of everolimus (edema). Swelling of the feet and hands, as well as rapid weight gain, are common symptoms. Any of these symptoms should be reported to your doctor right away.
Does everolimus make you tired?
Treatment with the mTOR inhibitors everolimus and temsirolimus has been linked to an increase in fatigue in cancer patients. Fatigue must be detected and managed early on.